Rapid Progression of Autoimmune Gastritis after Helicobacter pylori Eradication Therapy

Intern Med. 2023 Jun 1;62(11):1603-1609. doi: 10.2169/internalmedicine.0533-22. Epub 2022 Oct 19.

Abstract

We herein report a case of autoimmune gastritis (AIG) with rapid progression after Helicobacter pylori eradication therapy. The patient's previous gastritis had followed the course of type B gastritis before eradication therapy for many years. Immediately after eradication, we diagnosed her with AIG and carefully followed changes in the endoscopic and histopathological findings and serum markers. All of these clinical findings showed significant atrophic progression in the corporal area for approximately three years. We concluded that H. pylori eradication therapy exacerbated AIG in this case.

Keywords: Helicobacter pylori; atrophic gastritis; autoimmune gastritis; eradication therapy; pepsinogen; type B gastritis.

Publication types

  • Case Reports

MeSH terms

  • Atrophy
  • Female
  • Gastritis* / drug therapy
  • Gastritis, Atrophic* / drug therapy
  • Gastritis, Atrophic* / pathology
  • Helicobacter Infections* / diagnosis
  • Helicobacter pylori*
  • Humans